Skip to main content
OpenTrials
Completed

NCT Number: NCT03343821

Analysis of the French Balance and Daily Life (EVQ) Questionnaire for Evaluation of Balance in the Frail Elderly

The Balance and Daily Life questionnaire (EVQ) observes the adaption of the patient in six scenarios of daily life; it is a measurement of falls, but also an evaluation of the modifications taken to prevent future falls. This study will analyze the robustness of this questionnaire.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Accidental Fall

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Nimes

Nîmes, 30029, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is at least 65 years' old
  • The patient is fragile (< 8 score ≤ 11 SEGA score) hospitalized in the Physical Medicine and Functional Geriatric Readaptation service of the CHU Nîmes
  • The patient can walk autonomously for 20m (with or without a walking aid)
  • The patient is allowed to weight-bear

Exclusion criteria

  • The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent form
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The patient is forbidden to weight-bear
  • Comprehension problems preventing the accomplishment of the tasks
  • Major short-term memory problems preventing the accomplishment of the tasks

Treatment and study plan

Balance and daily life questionnaire

Other

Patients complete questionnaire

Primary outcomes

  1. Inter-evaluator reliability of Balance and Daily Life Questionnaire

    Time frame: Day 0

    Balance and Daily Life Questionnaire assessed by 2 evaluators

  2. Temporal stability of Balance and Daily Life Questionnaire

    Time frame: Day 3

    Balance and Daily Life Questionnaire given 3 days apart

Secondary outcomes

  1. Comparison of EVQ score to Timed Up and Go test

    Time frame: Day 0

    Timed Up and Go test (seconds)

  2. Comparison of EVQ score to Timed Up and Go test

    Time frame: Month 1

    Timed Up and Go test (seconds)

  3. Comparison of EVQ to unipedal stance test

    Time frame: Day 0

    Unipedal stance test (seconds)

  4. Comparison of EVQ to unipedal stance test

    Time frame: Month 1

    Unipedal stance test (seconds)

  5. Comparison of EVQ to Sternal Push Test

    Time frame: Day 0

    Sternal Push Test

  6. Comparison of EVQ to Sternal Push Test

    Time frame: Month 1

    Sternal Push Test

  7. Comparison of EVQ to Walking and talking test

    Time frame: Day 0

    Walking and talking test

  8. Comparison of EVQ to Walking and talking test

    Time frame: Month 1

    Walking and talking test

  9. Sensitivity of Balance and Daily Life Questionnaire to change

    Time frame: Month 1

    Balance and Daily Life Questionnaire given 30 days apart

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Acronym: EVQ

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Nov 17, 2017
Registry last updated
Dec 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.